Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Cannabidiol by Ananda Scientific for Opium (Opioid) Addiction: Likelihood of Approval
Cannabidiol is under clinical development by Ananda Scientific and currently in Phase II for Opium (Opioid) Addiction. According to GlobalData,...
Cannabidiol by Cannamore Biotechs for Ulcerative Colitis: Likelihood of Approval
Cannabidiol is under clinical development by Cannamore Biotechs and currently in Phase II for Ulcerative Colitis. According to GlobalData, Phase...
Cannabidiol by Jazz Pharmaceuticals for Rett Syndrome: Likelihood of Approval
Cannabidiol is under clinical development by Jazz Pharmaceuticals and currently in Phase II for Rett Syndrome. According to GlobalData, Phase...
Cannabidiol by Ananda Scientific for Pain: Likelihood of Approval
Cannabidiol is under clinical development by Ananda Scientific and currently in Phase I for Pain. According to GlobalData, Phase I...
Cannabidiol by Jazz Pharmaceuticals for Schizophrenia: Likelihood of Approval
Cannabidiol is under clinical development by Jazz Pharmaceuticals and currently in Phase II for Schizophrenia. According to GlobalData, Phase II...
Cannabidiol by Zynerba Pharmaceuticals for Partial Seizure: Likelihood of Approval
Cannabidiol is under clinical development by Zynerba Pharmaceuticals and currently in Phase II for Partial Seizure. According to GlobalData, Phase...
Cannabidiol by Jazz Pharmaceuticals for Developmental Disorders: Likelihood of Approval
Cannabidiol is under clinical development by Jazz Pharmaceuticals and currently in Phase II for Developmental Disorders. According to GlobalData, Phase...
Cannabidiol by Jazz Pharmaceuticals for Infantile Spasm (West Syndrome): Likelihood of Approval
Cannabidiol is under clinical development by Jazz Pharmaceuticals and currently in Phase III for Infantile Spasm (West Syndrome). According to...
Cannabidiol by EmpowerPharm for Social Anxiety Disorder (SAD/Social Phobia): Likelihood of Approval
Cannabidiol is under clinical development by EmpowerPharm and currently in Phase II for Social Anxiety Disorder (SAD/Social Phobia). According to...
Cannabidiol by Avata Biosciences for Epilepsy: Likelihood of Approval
Cannabidiol is under clinical development by Avata Biosciences and currently in Phase I for Epilepsy. According to GlobalData, Phase I...
Cannabidiol by Avata Biosciences for Schizophrenia: Likelihood of Approval
Cannabidiol is under clinical development by Avata Biosciences and currently in Phase I for Schizophrenia. According to GlobalData, Phase I...